Bryce Point Capital LLC Invests $822,000 in Masimo Corporation $MASI

Bryce Point Capital LLC acquired a new position in shares of Masimo Corporation (NASDAQ:MASI) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,885 shares of the medical equipment provider’s stock, valued at approximately $822,000.

Several other large investors also recently modified their holdings of the company. State of Michigan Retirement System grew its position in shares of Masimo by 1.9% during the 2nd quarter. State of Michigan Retirement System now owns 10,796 shares of the medical equipment provider’s stock worth $1,816,000 after buying an additional 200 shares during the period. Simon Quick Advisors LLC acquired a new stake in shares of Masimo during the 2nd quarter worth approximately $381,000. Strs Ohio grew its position in shares of Masimo by 39.5% during the 2nd quarter. Strs Ohio now owns 55,983 shares of the medical equipment provider’s stock worth $9,417,000 after buying an additional 15,848 shares during the period. Amalgamated Bank grew its position in shares of Masimo by 5.2% during the 2nd quarter. Amalgamated Bank now owns 21,743 shares of the medical equipment provider’s stock worth $3,658,000 after buying an additional 1,081 shares during the period. Finally, Retirement Systems of Alabama grew its position in shares of Masimo by 1.7% during the 2nd quarter. Retirement Systems of Alabama now owns 55,003 shares of the medical equipment provider’s stock worth $9,253,000 after buying an additional 916 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Masimo

In other Masimo news, Director William R. Jellison acquired 3,000 shares of the business’s stock in a transaction dated Monday, August 11th. The stock was bought at an average price of $145.98 per share, with a total value of $437,940.00. Following the completion of the acquisition, the director owned 4,790 shares of the company’s stock, valued at $699,244.20. This trade represents a 167.60% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 9.70% of the company’s stock.

Masimo Stock Performance

NASDAQ MASI opened at $144.96 on Tuesday. Masimo Corporation has a 52-week low of $133.70 and a 52-week high of $194.88. The company has a 50-day simple moving average of $144.80 and a 200 day simple moving average of $154.07. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. The company has a market capitalization of $7.87 billion, a PE ratio of -17.01 and a beta of 1.28.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The business had revenue of $617.00 million for the quarter. On average, research analysts predict that Masimo Corporation will post 4.1 EPS for the current year.

Analysts Set New Price Targets

MASI has been the subject of several recent analyst reports. Zacks Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 24th. Wall Street Zen raised shares of Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, October 14th. BTIG Research reiterated a “buy” rating and issued a $198.00 target price on shares of Masimo in a report on Thursday, September 11th. Piper Sandler boosted their price target on shares of Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research note on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $194.60.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.